Filing Details
- Accession Number:
- 0001209191-15-013522
- Form Type:
- 5
- Zero Holdings:
- No
- Publication Time:
- 2015-02-13 16:17:01
- Reporting Period:
- 2014-12-31
- Filing Date:
- 2015-02-13
- Accepted Time:
- 2015-02-13 16:17:01
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1215126 | G Margaret Mcglynn | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2011-11-22 | 31 | $28.00 | 1,088 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2011-12-06 | 33 | $29.66 | 1,088 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2011-12-07 | 9 | $29.19 | 1,088 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2012-08-10 | 15 | $51.23 | 1,088 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |
Footnotes
- As of 12/31/2014.